Neptune Wellness Solutions OTCPK:NEPT.F Stock Report Neptune Wellness Solutions Inc.
OTCPK:NEPT.F Stock Report
NEPT.F Stock Overview Operates as a consumer packaged goods company in Canada, the United States, and internationally. More details
Risk Analysis + 2 more risks
See All Risk Checks Neptune Wellness Solutions Inc. Competitors Price History & Performance
Summary of all time highs, changes and price drops for Neptune Wellness Solutions Historical stock prices Current Share Price US$0.000001 52 Week High US$0.93 52 Week Low US$0.000001 Beta 2.19 11 Month Change -99.99% 3 Month Change -99.99% 1 Year Change -100.00% 33 Year Change -100.00% 5 Year Change -100.00% Change since IPO -100.00%
Recent News & Updates Neptune Wellness Solutions Inc. Appoints Michael De Geus as Interim President and Cedrick Billequey as Interim COO Neptune Wellness Solutions Inc.(OTCPK:NEPT.F) dropped from NASDAQ Composite Index
Neptune Wellness Solutions Inc. to Report Q3, 2024 Results on Feb 16, 2024 Feb 17 Neptune Wellness Solutions Inc. announced delayed 10-Q filing Feb 16
Neptune Wellness Announces Receipt of Nasdaq Delisting Notice and Intention to Appeal Dec 05
Neptune Wellness Solutions Inc. (NasdaqCM:NEPT) entered into a non-binding Letter of Intent to acquire Datasys Group Inc. approximately $110 million. Nov 21 See more updates Neptune Wellness Solutions Inc. Appoints Michael De Geus as Interim President and Cedrick Billequey as Interim COO Neptune Wellness Solutions Inc.(OTCPK:NEPT.F) dropped from NASDAQ Composite Index
Neptune Wellness Solutions Inc. to Report Q3, 2024 Results on Feb 16, 2024 Feb 17 Neptune Wellness Solutions Inc. announced delayed 10-Q filing Feb 16
Neptune Wellness Announces Receipt of Nasdaq Delisting Notice and Intention to Appeal Dec 05
Neptune Wellness Solutions Inc. (NasdaqCM:NEPT) entered into a non-binding Letter of Intent to acquire Datasys Group Inc. approximately $110 million. Nov 21
Neptune Wellness Solutions Inc. Announces Completed Settlement of Class Action Lawsuit Oct 14
Neptune Wellness Solutions Inc. announced delayed 10-Q filing Aug 17
Neptune Wellness Solutions Inc. Announces CFO Changes Aug 05
Neptune Wellness Solutions Inc. announced delayed annual 10-K filing Jul 01 Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $4 million. May 17
Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $4 million. May 16
Neptune Wellness Solutions Inc. announced delayed 10-Q filing Feb 16
Neptune Wellness Solutions Announces Receipt of NASDAQ Notification Jan 07
Neptune Wellness Solutions Inc. Revises Revenue Guidance for the Second Quarter of Fiscal Year 2023 Nov 23 Neptune Wellness Solutions Inc. announced delayed 10-Q filing
PurCann Pharma Inc. completed the acquisition of Cannabis Assets of Neptune Wellness Solutions Inc. for CAD 5.2 million. Nov 10
Neptune Wellness Solutions Inc. Reaches Settlement in Shareholder Class Action Litigation Oct 22
PurCann Pharma Inc. entered into a binding agreement to acquire Cannabis Assets of Neptune Wellness Solutions Inc. for approximately CAD 6 million. Oct 19
PurCann Pharma Inc. entered into a binding agreement to acquire Cannabis Assets of Neptune Wellness Solutions Inc. for CAD 5.15 million. Oct 18
Neptune Wellness Solutions to divest cannabis assets for C$5.15M Oct 17 Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $6.000002 million. Oct 13
Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $6.000002 million.
Neptune Wellness launches $6M registered direct offering and concurrent private placement Oct 06
Neptune Wellness Solutions Inc. Announces Impairment Charges for the Three Months Ended June 30, 2022 Aug 16
Neptune Wellness Solutions Inc. to Report Q1, 2023 Results on Aug 15, 2022 Aug 13
Neptune Wellness Solutions Announces Voluntary Delisting from Toronto Stock Exchange Jul 30
Neptune Wellness announces voluntary delisting from TSX Jul 29
Neptune Wellness Solutions Inc., Annual General Meeting, Sep 27, 2022 Jul 21
Neptune Wellness Solutions GAAP EPS of -$17.50, revenue of $48.8M Jul 08
Neptune Wellness Solutions Inc. announced delayed amended 10-K filing Jul 02
Neptune Wellness Solutions Inc. announced delayed annual 10-K filing Jul 01
Neptune Wellness Solutions Inc. to Report Q4, 2022 Results on Jun 29, 2022 Jun 29 Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $5.000002 million. Jun 25
Neptune Wellness Solutions Inc. Appoints Raymond Silcock as Executive Vice President, Effective July 25, 2022
Neptune Wellness Solutions Inc. Launches New CPG-Focused Strategic Plan to Improve Path to Profitability Jun 09
High number of new and inexperienced directors Jun 02
Neptune Wellness Solutions Inc. Appoints Phil Sanford to Board of Directors and Audit Chair May 20
Neptune Wellness Expands Popular Mood Ring Portfolio with New Cannabis Strains Apr 20
Neptune Wellness: New Valuation As The Stock Bounces Back From The Bottom Mar 21 Neptune Wellness Launches Forest Remedies Multi-Omega 3-6-9 Supplements in 340+ Sprouts Farmers Market Stores Across U.S Mar 10
Neptune Granted 180-Day Extension to Meet Nasdaq Minimum Bid Requirement Mar 04
President recently bought US$384k worth of stock Mar 04
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Feb 12
Neptune Wellness Solutions Inc. Announces Management Changes Feb 11
Neptune Wellness Solutions Inc. to Report Q3, 2022 Results on Feb 10, 2022 Feb 04
Neptune Wellness Solutions Inc. Extends Mood Ring Product Line with In-Demand Pre-Rolls Launching in Ontario and Alberta Dec 21
Second quarter 2022 earnings released: CA$0.076 loss per share (vs CA$0.20 loss in 2Q 2021) Nov 17
High number of new directors Sep 14
High number of new directors Sep 13
High number of new directors Sep 10
Neptune Wellness Solutions Announces Receipt of Nasdaq Notification Sep 01
Independent Director Jane Pemberton has left the company Sep 01
Independent Director Frank Rochon has left the company Sep 01
Neptune Launches Forest Remedies Plant-Based Omega 3-6-9 Supplements Jul 24
Independent Chairman recently bought US$79k worth of stock Jul 23
Neptune Wellness Solutions Inc. Provides Revenue Guidance for the First Quarter Ended June 30, 2021 Jul 20
Full year 2021 earnings released: CA$1.38 loss per share (vs CA$0.68 loss in FY 2020) Jul 18
Neptune Wellness Solutions Inc. Announces Impairment Charges for the Fourth Quarter Ended March 31, 2021 Jul 16
Neptune Wellness Solutions Inc. Launches Three New Mood Ring Branded Cannabis Products Jun 11
Neptune Wellness Solutions trades higher on licensing agreement between Sprout Foods and CoComelon Jun 09
Neptune Wellness Solutions Inc. Announces the Launch of Panhashtm in Quebec May 28
Neptune Wellness' cannabis brand PanHash now available in Quebec May 27
Independent Director has left the company May 23
Neptune Wellness inks supply agreement with AGLC, expands Canadian footprint Apr 28
Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Neptune Wellness Solutions, Inc., of Class Action Lawsuit and Upcoming Deadline Apr 27
Glancy Prongay & Murray LLP Announces the Filing of Securities Class Action on Behalf of Neptune Wellness Solutions Inc. Investors Mar 21
Pomerantz LLP Announces the Filing of Class Action Against Neptune Wellness Solutions, Inc Mar 17
Neptune Wellness Solutions, Inc. Enters into Letter of Intent with Société québécoise du cannabis Mar 12
New 90-day low: US$1.40 Mar 05
Groundbreaking Research Finds Neptune's Patented Maxsimil® Fish Oil Up to 3.5 Times More Absorbable Than Standard Fish Oil Feb 25
Neptune Wellness Solutions Inc. Announces Cannabis Brand Mood Ring™ Is Now Available Through the Ontario Cannabis Store Feb 23
Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $55 million. Feb 20
Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute with Azpa Pharmaceuticals Pty. Ltd Feb 19
Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $18.6 million. Feb 18 Shareholder Returns NEPT.F US Personal Products US Market 7D -100.0% 2.7% 1.0% 1Y -100.0% -15.4% 33.1%
See full shareholder returns
Return vs Market: NEPT.F underperformed the US Market which returned 33.2% over the past year.
Price Volatility Is NEPT.F's price volatile compared to industry and market? NEPT.F volatility NEPT.F Average Weekly Movement 48.7% Personal Products Industry Average Movement 8.1% Market Average Movement 6.2% 10% most volatile stocks in US Market 15.6% 10% least volatile stocks in US Market 3.0%
Stable Share Price: NEPT.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: NEPT.F's weekly volatility has decreased from 56% to 49% over the past year, but is still higher than 75% of US stocks.
About the Company Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. It’s product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids. The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands.
Show more Neptune Wellness Solutions Inc. Fundamentals Summary How do Neptune Wellness Solutions's earnings and revenue compare to its market cap? NEPT.F fundamental statistics Market cap US$4.00 Earnings (TTM ) -US$53.52m Revenue (TTM ) US$39.11m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) NEPT.F income statement (TTM ) Revenue US$39.11m Cost of Revenue US$39.87m Gross Profit -US$758.79k Other Expenses US$52.76m Earnings -US$53.52m
Last Reported Earnings
Dec 31, 2023
Earnings per share (EPS) -10.86 Gross Margin -1.94% Net Profit Margin -136.83% Debt/Equity Ratio -49.8%
How did NEPT.F perform over the long term?
See historical performance and comparison
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
